HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert E Coleman Selected Research

Bone Diseases (Bone Disease)

5/2013Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug.
9/2012Adjuvant bone-targeted therapy to prevent metastasis: lessons from the AZURE study.
6/2010Potential anticancer properties of bisphosphonates.
3/2010Biomarkers of bone turnover in oncology: applications in diagnosis and treatment.
3/2010The use of a point of care device for monitoring the bone resorption biomarker urinary N-telopeptide in cancer patients with bone metastases.
1/2010Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.
1/2010Bisphosphonates as treatment of bone metastases.
11/2009Bisphosphonates in breast cancer: teaching an old dog new tricks.
1/2009Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
7/2008Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Robert E Coleman Research Topics

Disease

60Breast Neoplasms (Breast Cancer)
05/2015 - 01/2002
47Neoplasms (Cancer)
05/2015 - 01/2002
46Neoplasm Metastasis (Metastasis)
05/2015 - 01/2002
21Bone Resorption
05/2013 - 05/2002
19Bone Diseases (Bone Disease)
05/2013 - 02/2003
17Prostatic Neoplasms (Prostate Cancer)
02/2014 - 12/2002
9Pain (Aches)
02/2012 - 12/2002
8Multiple Myeloma
05/2013 - 02/2003
6Carcinoma (Carcinomatosis)
04/2010 - 01/2003
4Osteoporosis
01/2013 - 01/2002
4Postmenopausal Osteoporosis
02/2012 - 09/2007
4Lung Neoplasms (Lung Cancer)
07/2008 - 01/2004
3Spontaneous Fractures (Pathological Fracture)
10/2010 - 01/2004
3Necrosis
01/2010 - 08/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2008 - 06/2004
3Disease Progression
01/2005 - 05/2002
2Osteonecrosis (Kienbock's Disease)
07/2013 - 10/2011
2Premature Menopause
06/2013 - 01/2008
2Spinal Cord Compression
10/2010 - 01/2004
2Fatigue
03/2010 - 02/2003
2Lymphoma (Lymphomas)
10/2009 - 11/2006
1Exanthema (Rash)
05/2015
1Diarrhea
05/2015
1Hypocalcemia
02/2014
1Renal Insufficiency (Renal Failure)
02/2014
1Placental Site Trophoblastic Tumor
07/2012
1Adenocarcinoma
06/2012
1Giant Cell Tumors (Giant Cell Tumor)
02/2012
1Secondary Hyperparathyroidism
01/2012
1Arthralgia (Joint Pain)
04/2010
1Chronic Disease (Chronic Diseases)
03/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2009
1Body Weight (Weight, Body)
08/2008
1Endometrial Neoplasms (Endometrial Cancer)
01/2008

Drug/Important Bio-Agent (IBA)

44zoledronic acid (zoledronate)FDA Link
01/2015 - 12/2002
28DiphosphonatesIBA
02/2014 - 01/2002
14pamidronate (APD)FDA LinkGeneric
11/2012 - 12/2002
12Doxorubicin (Adriamycin)FDA LinkGeneric
06/2012 - 01/2003
10Biological Markers (Surrogate Marker)IBA
05/2013 - 05/2002
8HormonesIBA
06/2014 - 05/2004
8collagen type I trimeric cross-linked peptideIBA
03/2010 - 05/2002
7denosumabFDA Link
02/2014 - 02/2006
7Aromatase (CYP19)IBA
06/2013 - 02/2007
7Collagen Type I (Type I Collagen)IBA
01/2011 - 05/2002
7Clodronic Acid (Clodronate)IBA
04/2006 - 12/2002
6Aromatase InhibitorsIBA
07/2011 - 01/2008
5TamoxifenFDA LinkGeneric
03/2012 - 03/2004
4Estrogens (Estrogen)FDA Link
10/2012 - 03/2004
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2010 - 01/2003
4ibandronic acid (Boniva)FDA Link
10/2008 - 01/2004
3taxaneIBA
05/2015 - 08/2011
3exemestane (Aromasin)FDA Link
03/2012 - 03/2004
3docetaxel (Taxotere)FDA Link
08/2011 - 05/2005
3CalciumIBA
07/2011 - 05/2002
3Alkaline PhosphataseIBA
10/2010 - 01/2005
3Caspase 3 (Caspase-3)IBA
01/2010 - 08/2008
3Paclitaxel (Taxol)FDA LinkGeneric
01/2010 - 01/2003
3CreatinineIBA
03/2008 - 02/2003
3OsteoprotegerinIBA
04/2006 - 02/2003
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
05/2015 - 01/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2012 - 10/2010
2RANK LigandIBA
02/2012 - 02/2006
2CyclinsIBA
01/2010 - 10/2009
2anastrozole (Arimidex)FDA LinkGeneric
10/2008 - 03/2008
1lapatinib (GW572016)FDA Link
05/2015
1TaxoidsIBA
05/2015
1trastuzumab (Herceptin)FDA Link
05/2015
1P 11 (P-11)IBA
05/2015
1130-nm albumin-bound paclitaxelIBA
01/2015
1gemcitabineFDA Link
01/2015
1activin AIBA
01/2015
1Trypan BlueFDA Link
01/2015
1FollistatinIBA
01/2015
1Activins (Activin)IBA
01/2015
1Carboplatin (JM8)FDA LinkGeneric
01/2015
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2014
1Fibronectins (Fibronectin)IBA
04/2014
1Mevalonic Acid (Mevalonate)IBA
05/2013
1ProgesteroneFDA LinkGeneric
10/2012
1Goserelin (Zoladex)FDA Link
09/2012
1Parathyroid Hormone (Parathormone)IBA
01/2012
1Epirubicin (Ellence)FDA LinkGeneric
08/2011
1Vitamin DFDA LinkGeneric
07/2011
1Bone Density Conservation AgentsIBA
12/2010
1Testosterone (Sustanon)FDA Link
03/2010
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2009
1AntibodiesIBA
08/2008
1boron oxide (BO2)IBA
07/2008
1letrozole (Femara)FDA LinkGeneric
03/2008
1Peptide Hydrolases (Proteases)IBA
12/2007
1Matrix MetalloproteinasesIBA
12/2007
1Cysteine Proteases (Cysteine Protease)IBA
12/2007
1Plasminogen Activators (Plasminogen Activator)IBA
12/2007
1Collagen Type II (Type II Collagen)IBA
09/2007

Therapy/Procedure

18Drug Therapy (Chemotherapy)
01/2015 - 10/2002
4Radiotherapy
10/2010 - 01/2004
2Castration
02/2014 - 02/2012
2Heterologous Transplantation (Xenotransplantation)
12/2002 - 12/2002
1Intravenous Injections
08/2008
1Intraperitoneal Injections
08/2008